PHARMOSA BIOPHARM INCPHARMOSA BIOPHARM INCPHARMOSA BIOPHARM INC

PHARMOSA BIOPHARM INC

No trades
See on Supercharts

6875 fundamentals

PHARMOSA BIOPHARM INC financial statements, including revenue, expenses, and profit

The total revenue of 6875 for the last quarter is 117.05 M TWD, and it's 186.15% higher compared to the previous quarter. The net income of Q4 24 is 34.93 M TWD.

Q3 '22
Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: TWD
Q3 '22
Q1 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth